LYA-Onco 1
Oncology
Metastatic solid tumors in label-defined populations
Route: Infusion | PI updated: Jan 8, 2026
Lya Provider Hub: Built by Biopharma for Providers
Unified US-only provider platform for therapy access, scientific exchange, and workflow support.
Provider-facing experience
Promotional and medical content separated
No treatment recommendations from AI
MFA and audit logging required
Verified HCP Accounts
18,204
+6.4% MoM
Active Therapy Starts
2,931
+11.2% QoQ
Prior Auth In Progress
684
74% within SLA
Medical Info Requests
127
96% on-time responses
Safety Reports Open
34
100% follow-up within SLA
Therapy Portfolio
Quick switch between Lya therapies by specialty and route.
LYA-Immuno 2
Rheumatology
Moderate to severe autoimmune disease
Route: Subcutaneous | PI updated: Dec 12, 2025
LYA-Neuro 3
Neurology
Relapsing neurologic disease
Route: Infusion | PI updated: Feb 2, 2026
Current Work Queues
Provider-initiated access and referral updates.
BV-44109: Benefits Verification
LYA-Onco 1 | Submitted Feb 16, 2026
In Review
PA-98220: Prior Authorization
LYA-Immuno 2 | Submitted Feb 15, 2026
Additional Docs Requested
REF-3011: Patient Support Referral
Austin Cancer Center | LYA-Onco 1
Intake Complete
REF-3018: Patient Support Referral
North Bay Rheumatology | LYA-Immuno 2
Awaiting Signature
Strategic Modules
Focused pages added for better readability and execution.
MVP Scope (Phase 1)
Required launch features configured in this hub.
- Secure HCP authentication
- Multi-therapy dashboard
- Prescribing info module
- Reimbursement tools
- Patient referral system
- Medical Information portal
- Safety and product complaint intake
- GenAI assistant v1 with guardrails
- Basic analytics
- MLR governance controls
Success Metrics
Operational goals monitored for provider value and compliance.
- Reduced time to therapy initiation
- Improved PA and appeal cycle times
- Higher provider self-service completion across specialties
- Medical information request satisfaction
- Safety report timeliness and completion
- Zero regulatory violations
- AI safe-response rate >= 99.5%